Effect of Pre- and Postoperative ESP Block on Frontal QRS-T Angle in Laparoscopic Cholecystectomy
Launched by HARRAN UNIVERSITY · Jul 9, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a type of pain relief called the Erector Spinae Plane (ESP) block, given either before or after surgery, affects the heart's electrical activity in people having a laparoscopic gallbladder removal. The heart’s electrical activity will be measured using a test called an electrocardiogram (ECG) before surgery and one hour after. Researchers want to see if the timing of this pain relief method influences a specific heart measurement that can show how stable the heart’s rhythm is during the recovery period.
Adults aged 18 to 65 who are generally healthy and scheduled for elective laparoscopic gallbladder surgery may be eligible to join. To participate, patients need to have a normal heart rhythm before surgery and must give informed consent. If you join the study, you will be randomly placed into one of three groups: no ESP block, ESP block before surgery, or ESP block after surgery. You will have ECG tests before and after the procedure to monitor any changes. This study aims to help doctors understand the safest way to use this pain relief technique to protect the heart during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-65 years
- • ASA physical status I-II
- • Scheduled for elective laparoscopic cholecystectomy
- • Voluntary written informed consent obtained
- • Normal preoperative 12-lead ECG (no conduction abnormalities or arrhythmias)
- Exclusion Criteria:
- • History of cardiac disease (e.g., arrhythmia, myocardial infarction, heart failure)
- • Current use of medications affecting cardiac conduction (e.g., antiarrhythmics, beta-blockers)
- • Known allergy to local anesthetics
- • Coagulation disorders or current anticoagulant therapy
- • Pregnancy or breastfeeding
- • Local infection or anatomical deformity at the ESP block injection site
- • Patients with psychiatric or neurological disorders impairing cooperation
About Harran University
Harran University is a distinguished academic institution committed to advancing healthcare through innovative research and clinical trials. With a focus on enhancing patient outcomes, the university leverages its multidisciplinary expertise to conduct rigorous scientific investigations. Harran University fosters collaboration among researchers, clinicians, and industry partners to explore novel therapeutic approaches and improve clinical practices. Through its dedication to ethical standards and patient safety, Harran University aims to contribute significantly to the body of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
şanlıurfa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported